Steward Partners Investment Advisory LLC Buys 600 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Steward Partners Investment Advisory LLC boosted its stake in Bath & Body Works, Inc. (NYSE:BBWIGet Rating) by 14.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,662 shares of the company’s stock after purchasing an additional 600 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Bath & Body Works were worth $126,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in BBWI. Steadfast Capital Management LP increased its position in Bath & Body Works by 7,923.4% in the 1st quarter. Steadfast Capital Management LP now owns 6,760,507 shares of the company’s stock valued at $323,152,000 after acquiring an additional 6,676,247 shares during the period. Alecta Tjanstepension Omsesidigt increased its position in Bath & Body Works by 16.7% in the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 3,500,000 shares of the company’s stock valued at $94,220,000 after acquiring an additional 500,000 shares during the period. Arrowstreet Capital Limited Partnership increased its position in Bath & Body Works by 34.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,830,984 shares of the company’s stock valued at $135,321,000 after acquiring an additional 726,384 shares during the period. Invesco Ltd. increased its position in Bath & Body Works by 26.3% in the 1st quarter. Invesco Ltd. now owns 2,584,966 shares of the company’s stock valued at $123,561,000 after acquiring an additional 538,353 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in Bath & Body Works in the 1st quarter valued at approximately $84,383,000. Institutional investors own 96.19% of the company’s stock.

Bath & Body Works Stock Performance

NYSE BBWI opened at $34.43 on Friday. Bath & Body Works, Inc. has a 52-week low of $25.75 and a 52-week high of $82.00. The company has a 50-day simple moving average of $35.12 and a 200 day simple moving average of $36.90. The company has a market capitalization of $7.86 billion, a PE ratio of 9.13, a price-to-earnings-growth ratio of 0.77 and a beta of 1.69.

Bath & Body Works (NYSE:BBWIGet Rating) last posted its quarterly earnings data on Wednesday, August 17th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Bath & Body Works had a net margin of 12.31% and a negative return on equity of 52.60%. The business had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the company posted $1.34 earnings per share. The firm’s quarterly revenue was down 5.1% compared to the same quarter last year. As a group, analysts forecast that Bath & Body Works, Inc. will post 2.88 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 2nd. Investors of record on Friday, November 18th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, November 17th. This represents a $0.80 dividend on an annualized basis and a yield of 2.32%. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.22%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on BBWI shares. Wedbush cut shares of Bath & Body Works to an “underperform” rating in a research report on Monday, August 22nd. B. Riley increased their price objective on shares of Bath & Body Works from $44.00 to $48.00 in a research report on Tuesday, August 16th. Credit Suisse Group decreased their price objective on shares of Bath & Body Works from $49.00 to $42.00 and set a “neutral” rating for the company in a research report on Thursday, August 18th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $41.00 to $46.00 in a research report on Friday, August 19th. Finally, Piper Sandler decreased their price objective on shares of Bath & Body Works to $44.00 in a research report on Friday, July 22nd. One analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $51.05.

Bath & Body Works Profile

(Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIGet Rating).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.